CN101212968B - 3,5-二取代的和3,5,7-三取代的-3H-噁唑并以及3H-噻唑并[4,5-d]嘧啶-2-酮化合物及其前药 - Google Patents

3,5-二取代的和3,5,7-三取代的-3H-噁唑并以及3H-噻唑并[4,5-d]嘧啶-2-酮化合物及其前药 Download PDF

Info

Publication number
CN101212968B
CN101212968B CN2005800431016A CN200580043101A CN101212968B CN 101212968 B CN101212968 B CN 101212968B CN 2005800431016 A CN2005800431016 A CN 2005800431016A CN 200580043101 A CN200580043101 A CN 200580043101A CN 101212968 B CN101212968 B CN 101212968B
Authority
CN
China
Prior art keywords
chemical compound
amino
thiazole
preparation
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN2005800431016A
Other languages
English (en)
Chinese (zh)
Other versions
CN101212968A (zh
Inventor
S·E·韦伯
G·J·海力
J·R·伦诺克斯
A·X·项
E·J·鲁登
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Anadys Pharmaceuticals Inc
Original Assignee
Anadys Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anadys Pharmaceuticals Inc filed Critical Anadys Pharmaceuticals Inc
Priority claimed from PCT/US2005/045589 external-priority patent/WO2006066080A1/en
Publication of CN101212968A publication Critical patent/CN101212968A/zh
Application granted granted Critical
Publication of CN101212968B publication Critical patent/CN101212968B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN2005800431016A 2004-12-17 2005-12-16 3,5-二取代的和3,5,7-三取代的-3H-噁唑并以及3H-噻唑并[4,5-d]嘧啶-2-酮化合物及其前药 Active CN101212968B (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US63663304P 2004-12-17 2004-12-17
US63663404P 2004-12-17 2004-12-17
US60/636,634 2004-12-17
US60/636,633 2004-12-17
PCT/US2005/045589 WO2006066080A1 (en) 2004-12-17 2005-12-16 3, 5-DISUBSTITUTED AND 3,5,7-TRISUBSTITUTED-3H-OXAZOLO AND 3H-THIAZOLO [4,5-d]PYRIMIDIN-2-ONE COMPOUNDS AND PRODRUGS THEREOF

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN201110291130.1A Division CN102504001B (zh) 2004-12-17 2005-12-16 3,5-二取代的和3,5,7-三取代的-3H-噁唑并以及3H-噻唑并[4,5-d]嘧啶-2-酮化合物及其前药

Publications (2)

Publication Number Publication Date
CN101212968A CN101212968A (zh) 2008-07-02
CN101212968B true CN101212968B (zh) 2011-11-16

Family

ID=39612457

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2005800431016A Active CN101212968B (zh) 2004-12-17 2005-12-16 3,5-二取代的和3,5,7-三取代的-3H-噁唑并以及3H-噻唑并[4,5-d]嘧啶-2-酮化合物及其前药

Country Status (2)

Country Link
CN (1) CN101212968B (xx)
ZA (1) ZA200705791B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017531655A (ja) * 2014-10-11 2017-10-26 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 感染性疾患の処置に使用するための化合物
DK3230298T3 (da) * 2014-12-08 2021-03-22 Hoffmann La Roche 3-substituerede 5-amino-6H-thiazolo[4,5-d]pyrimidin-2,7-dion forbindelser til behandling og forebyggelse af virusinfektion
CA2979490C (en) 2015-03-16 2023-07-18 F. Hoffmann-La Roche Ag Combined treatment with a tlr7 agonist and an hbv capsid assembly inhibitor
JP6779232B2 (ja) * 2015-05-08 2020-11-04 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ ウイルス感染の治療又は予防のための新規オキサチオランカルボン酸と誘導体
EP3294746B1 (en) * 2015-05-12 2021-10-06 F. Hoffmann-La Roche AG Substituted aminothiazolopyrimidinedione derivatives for the treatment and prophylaxis of virus infection
WO2017001307A1 (en) * 2015-06-30 2017-01-05 F. Hoffmann-La Roche Ag Novel substituted aminothiazolopyrimidinedione for the treatment and prophylaxis of virus infection
CN108424432B (zh) * 2017-07-13 2021-04-23 上海兆维科技发展有限公司 一种3’-氧-甲氧乙基核苷的制备方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5041426A (en) * 1987-12-21 1991-08-20 Brigham Young University Immune system enhancing 3-β-d-ribofuranosylthiazolo[4,5-d]pyridimine nucleosides and nucleotides
US6787541B1 (en) * 1999-07-01 2004-09-07 Vernalis Research Limited Thieno-and furopyrimidine derivatives as A2A-receptor antagonists
CN1553773A (zh) * 2001-07-12 2004-12-08 �����ɷ� 用作杀真菌剂的噻唑并[4,5-b]吡啶

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5041426A (en) * 1987-12-21 1991-08-20 Brigham Young University Immune system enhancing 3-β-d-ribofuranosylthiazolo[4,5-d]pyridimine nucleosides and nucleotides
US6787541B1 (en) * 1999-07-01 2004-09-07 Vernalis Research Limited Thieno-and furopyrimidine derivatives as A2A-receptor antagonists
CN1553773A (zh) * 2001-07-12 2004-12-08 �����ɷ� 用作杀真菌剂的噻唑并[4,5-b]吡啶

Also Published As

Publication number Publication date
ZA200705791B (en) 2010-01-27
CN101212968A (zh) 2008-07-02

Similar Documents

Publication Publication Date Title
CN102504001B (zh) 3,5-二取代的和3,5,7-三取代的-3H-噁唑并以及3H-噻唑并[4,5-d]嘧啶-2-酮化合物及其前药
CN101516192B (zh) 5-氨基-3-(3'-脱氧-β-D-呋喃核糖基)-噻唑并[4,5-d]嘧啶-2,7-二酮的前药
CN101501039B (zh) 吡咯并[1,2-b]哒嗪酮化合物
CN101212968B (zh) 3,5-二取代的和3,5,7-三取代的-3H-噁唑并以及3H-噻唑并[4,5-d]嘧啶-2-酮化合物及其前药
TW200526237A (en) Administration of TLR7 ligands and prodrugs thereof for treatment of infection by hepatitis C virus
EP1758916B1 (en) 3-BETA-D-RIBOFURANOSYLTHIAZOLO[4,5-d]PYRIDIMINE NUCLEOSIDES AND USES THEREOF
CN102316871B (zh) [1，2，4]噻二嗪1，1-二氧化合物
CN1845745B (zh) Tlr7配体及其前药在制备用于治疗丙型肝炎病毒感染的药物中的用途
CN101605457B (zh) 5-氨基-3-(2'-0-乙酰基-3'-脱氧-β-D-呋喃核糖基)-3H-噻唑[4,5-d]嘧啶-2-酮的对甲苯磺酸盐及制备方法
KR100880298B1 (ko) ３-β-Ｄ-리보푸라노실티아졸로[４,５-ｄ]피리미딘뉴클레오시드 및 이의 용도

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant